Considering that metabolic syndrome is regarded as a clinical manifestation of insulin resistance, the increase in CRP levels may indirectly reflect progressive metabolic deterioration in individuals with higher degrees of obesity [14]. This evidence concerns the gene CRP and obesity disorder.